2. ASIA 2 X 27

2. ASIA 2 X 27 Asia vulnerable to U.S.-style accounting fiascos despite reforms

3. Spore 2 X 20 No quick relief for fussy Singaporeans

4. Drug 3 X 20 Bristol-Myers, Merck cases mark struggles of drug industry